Citigroup’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $6 | Buy |
+1
| New | +$10 | ﹤0.01% | 5840 |
|
|
2024
Q1 | – | Hold |
0
| – | -$2 | – | 5857 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5664 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5637 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5533 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5430 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5732 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6324 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6666 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6602 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6093 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6302 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6404 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7368 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7633 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7604 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7679 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7779 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7806 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7824 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7858 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7812 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7837 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7869 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7740 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7676 |
|
|
2017
Q4 | – | Sell |
-3
| Closed | -$2.32K | – | 7655 |
|
|
2017
Q3 | $3K | Hold |
3
| – | – | ﹤0.01% | 6969 |
|
|
2017
Q2 | $3K | Hold |
3
| – | – | ﹤0.01% | 6906 |
|
|
2017
Q1 | $3K | Hold |
3
| – | – | ﹤0.01% | 6943 |
|
|
2016
Q4 | $3K | Sell |
3
-6
| -67% | -$6.2K | ﹤0.01% | 7029 |
|
|
2016
Q3 | $17K | Hold |
9
| – | – | ﹤0.01% | 6294 |
|
|
2016
Q2 | $15K | Sell |
9
-1
| -10% | -$1.69K | ﹤0.01% | 6329 |
|
|
2016
Q1 | $18K | Hold |
10
| – | – | ﹤0.01% | 6598 |
|
|
2015
Q4 | $16K | Buy |
10
+1
| +11% | +$1.77K | ﹤0.01% | 6604 |
|
|
2015
Q3 | $15K | Buy |
9
+1
| +13% | +$2.41K | ﹤0.01% | 6219 |
|
|
2015
Q2 | $22K | Buy |
8
+3
| +60% | +$7.79K | ﹤0.01% | 6052 |
|
|
2015
Q1 | $14K | Buy |
5
+4
| +400% | +$11.1K | ﹤0.01% | 6293 |
|
|
2014
Q4 | $2K | Buy |
+1
| New | +$2.58K | ﹤0.01% | 6878 |
|
|
2014
Q3 | – | Sell |
-1
| Closed | -$3.25K | – | 6934 |
|
|
2014
Q2 | $4K | Buy |
+1
| New | +$3.56K | ﹤0.01% | 6551 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 7208 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 7156 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 6982 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 6796 |
|
Other funds holding TRIB
Citigroup's TRIB Position: Q3 2026 in Review
Citigroup opened a new position in Trinity Biotech (TRIB) in Q3 2026: 1 share worth $6. The stake represents ﹤0.01% of the portfolio and ranks #5840 among its holdings. This is a return to the name: Citigroup previously reported a position in TRIB as recently as Q3 2017.
Citigroup first reported a position in TRIB in Q2 2014 and has held it in 14 quarters since. The position peaked at $22K in Q2 2015. 3 funds tracked by Wall St. Rank hold TRIB as of Q3 2026.
- Citigroup held 1 share of Trinity Biotech worth $6 as of Q3 2026.
- Trinity Biotech was a new Citigroup position in Q3 2026.
- Trinity Biotech made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5840 holding.
- Citigroup first reported a position in Trinity Biotech in Q2 2014 and has held it in 14 quarters since.
- Citigroup's Trinity Biotech position peaked at $22K in Q2 2015.
- 3 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.